choya
2021-08-05
gd
Moderna gained over 2% and reached record high<blockquote>Moderna涨超2%创历史新高</blockquote>
免责声明:上述内容仅代表发帖人个人观点,不构成本平台的任何投资建议。
分享至
微信
复制链接
精彩评论
我们需要你的真知灼见来填补这片空白
打开APP,发表看法
APP内打开
发表看法
4
{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":899876927,"tweetId":"899876927","gmtCreate":1628175758169,"gmtModify":1633752898100,"author":{"id":3585264987238241,"idStr":"3585264987238241","authorId":3585264987238241,"authorIdStr":"3585264987238241","name":"choya","avatar":"https://static.tigerbbs.com/bf32f96fd67870273541927f4a6ed9e6","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":11,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":5,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>gd</p></body></html>","htmlText":"<html><head></head><body><p>gd</p></body></html>","text":"gd","highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/899876927","repostId":1106584329,"repostType":4,"repost":{"id":"1106584329","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1628171968,"share":"https://www.laohu8.com/m/news/1106584329?lang=zh_CN&edition=full","pubTime":"2021-08-05 21:59","market":"us","language":"en","title":"Moderna gained over 2% and reached record high<blockquote>Moderna涨超2%创历史新高</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1106584329","media":"Tiger Newspress","summary":"(Aug 5) Moderna beat on income and revenue in its Q2 earnings. Moderna's COVID vaccine shows 93% eff","content":"<p>(Aug 5) Moderna beat on income and revenue in its Q2 earnings. Moderna's COVID vaccine shows 93% effectiveness six months after second dose</p><p><blockquote>(8月5日)Moderna在第二季度收益中表现出色。Moderna的新冠疫苗在第二剂后六个月显示出93%的有效性</blockquote></p><p> <img src=\"https://static.tigerbbs.com/cc2622d5607faa3daa3e1cef13fc4bdf\" tg-width=\"1129\" tg-height=\"653\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> Moderna says that its COVID-19 vaccine is 93% effective six months after the second dose.</p><p><blockquote>Moderna表示,其COVID-19疫苗在第二剂疫苗接种六个月后的有效率为93%。</blockquote></p><p> That's just one percentage point lower than the 94% effectiveness reported in its initial clinical trial that led to the vaccine's Emergency Use Authorization.</p><p><blockquote>这仅比导致该疫苗获得紧急使用授权的初始临床试验中报告的94%有效性低一个百分点。</blockquote></p><p> Moderna said the sustained efficacy is based on a final analysis of the phase 3 COVE study. The company made the announcement during this morning's Q2 2021 earnings call presentation.</p><p><blockquote>Moderna表示,持续的疗效是基于对3期COVE研究的最终分析。该公司在今天上午举行的2021年第二季度看涨期权收益发布会上宣布了这一消息。</blockquote></p><p> However, the company said it expects antibody levels created by the vaccine to eventually wane, making booster shots likely.</p><p><blockquote>然而,该公司表示,预计疫苗产生的抗体水平最终会下降,因此有可能进行加强注射。</blockquote></p><p> CEO Stephane Bancel also said Moderna will not manufacture more than the 800M to 1B doses already planned this year because of capacity constraints and is not taking additional orders for deliveries this year.</p><p><blockquote>首席执行官Stephane Bancel还表示,由于产能限制,Moderna今年不会生产超过计划的8亿至10亿剂疫苗,并且今年不会接受额外的交付订单。</blockquote></p><p> Moderna beat on income and revenue in its Q2 earnings.</p><p><blockquote>Moderna第二季度收益和营收均超出预期。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna gained over 2% and reached record high<blockquote>Moderna涨超2%创历史新高</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna gained over 2% and reached record high<blockquote>Moderna涨超2%创历史新高</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-08-05 21:59</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>(Aug 5) Moderna beat on income and revenue in its Q2 earnings. Moderna's COVID vaccine shows 93% effectiveness six months after second dose</p><p><blockquote>(8月5日)Moderna在第二季度收益中表现出色。Moderna的新冠疫苗在第二剂后六个月显示出93%的有效性</blockquote></p><p> <img src=\"https://static.tigerbbs.com/cc2622d5607faa3daa3e1cef13fc4bdf\" tg-width=\"1129\" tg-height=\"653\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> Moderna says that its COVID-19 vaccine is 93% effective six months after the second dose.</p><p><blockquote>Moderna表示,其COVID-19疫苗在第二剂疫苗接种六个月后的有效率为93%。</blockquote></p><p> That's just one percentage point lower than the 94% effectiveness reported in its initial clinical trial that led to the vaccine's Emergency Use Authorization.</p><p><blockquote>这仅比导致该疫苗获得紧急使用授权的初始临床试验中报告的94%有效性低一个百分点。</blockquote></p><p> Moderna said the sustained efficacy is based on a final analysis of the phase 3 COVE study. The company made the announcement during this morning's Q2 2021 earnings call presentation.</p><p><blockquote>Moderna表示,持续的疗效是基于对3期COVE研究的最终分析。该公司在今天上午举行的2021年第二季度看涨期权收益发布会上宣布了这一消息。</blockquote></p><p> However, the company said it expects antibody levels created by the vaccine to eventually wane, making booster shots likely.</p><p><blockquote>然而,该公司表示,预计疫苗产生的抗体水平最终会下降,因此有可能进行加强注射。</blockquote></p><p> CEO Stephane Bancel also said Moderna will not manufacture more than the 800M to 1B doses already planned this year because of capacity constraints and is not taking additional orders for deliveries this year.</p><p><blockquote>首席执行官Stephane Bancel还表示,由于产能限制,Moderna今年不会生产超过计划的8亿至10亿剂疫苗,并且今年不会接受额外的交付订单。</blockquote></p><p> Moderna beat on income and revenue in its Q2 earnings.</p><p><blockquote>Moderna第二季度收益和营收均超出预期。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1106584329","content_text":"(Aug 5) Moderna beat on income and revenue in its Q2 earnings. Moderna's COVID vaccine shows 93% effectiveness six months after second dose\n\nModerna says that its COVID-19 vaccine is 93% effective six months after the second dose.\nThat's just one percentage point lower than the 94% effectiveness reported in its initial clinical trial that led to the vaccine's Emergency Use Authorization.\nModerna said the sustained efficacy is based on a final analysis of the phase 3 COVE study. The company made the announcement during this morning's Q2 2021 earnings call presentation.\nHowever, the company said it expects antibody levels created by the vaccine to eventually wane, making booster shots likely.\nCEO Stephane Bancel also said Moderna will not manufacture more than the 800M to 1B doses already planned this year because of capacity constraints and is not taking additional orders for deliveries this year.\nModerna beat on income and revenue in its Q2 earnings.","news_type":1,"symbols_score_info":{"MRNA":0.9}},"isVote":1,"tweetType":1,"viewCount":1441,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":2,"xxTargetLangEnum":"ORIG"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/899876927"}
精彩评论